Minimally invasive liver surgery (MILS) has doubled in incidence from 2013 to 2022, now representing 25.2% of liver resections in France. Major liver resections, primary, and secondary malignant tumors show the highest annual increases. University hospitals and high-volume centers are leading the adoption of MILS. Conversely, open liver surgery rates are decreasing across all indications and institutions, indicating a significant trend reversal favoring MILS adoption in the country.
Journal Article by Deyrat J, Fuks D (…) Tzedakis S et 8 al. in Surg Endosc
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.